Published in Crit Care on June 14, 2004
The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients. Anemia (2013) 0.80
Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations. Int J Angiol (2011) 0.80
Preanesthetic Assessment of the Jehovah's Witness Patient. Ochsner J (2012) 0.79
Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. Support Care Cancer (2009) 0.78
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet (1996) 2.83
The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg (2002) 2.20
Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med (1998) 1.95
Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion (1998) 1.93
Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res (2002) 1.68
Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness. N Engl J Med (2002) 1.43
A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41
Erythropoietin therapy. N Engl J Med (1997) 1.25
The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am (1996) 1.23
Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum (1998) 1.18
Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg (2002) 1.16
Preoperative anemia in colon cancer: assessment of risk factors. Am Surg (2002) 1.15
Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop (Belle Mead NJ) (1996) 1.09
Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang (2000) 1.05
Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion (1993) 1.05
Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery (2001) 1.03
Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med (1998) 1.02
Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med (2001) 1.01
Perceptions and preferences of autologous blood donors. Transfusion (1998) 1.01
A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop (Belle Mead NJ) (1996) 0.98
Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol Oncol Clin North Am (2000) 0.97
Adverse effect of blood transfusions on patient survival after resection of rectal cancer. Can J Surg (1988) 0.87
Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg (2001) 0.87
Progress toward a pathogen-free blood supply. Clin Infect Dis (2003) 0.85
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion (1994) 0.85
Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg (2003) 0.85
Transfusion options in total joint arthroplasty. J Arthroplasty (2002) 0.84
Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg (1995) 0.83
The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope (2002) 0.83
Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery. Acta Anaesthesiol Scand (2003) 0.83
Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat (2003) 0.82
Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion (1992) 0.81
Minimal effective dosage of recombinant human erythropoietin in spinal surgery. Clin Orthop Relat Res (2003) 0.81
The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy. J Urol (2000) 0.80
Bloodless medicine and surgery in the OR and beyond. AORN J (2002) 0.80
Influence of erythropoietin on transfusion requirements in patients receiving preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum (1999) 0.80
Immunological aspects of blood transfusions. Blood Rev (2000) 0.80
Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction. J South Orthop Assoc (2000) 0.80
Epoetin alpha in elective coronary and valve surgery in Jehovah's Witnesses patients. Experience in 45 patients. Minerva Cardioangiol (2002) 0.79
Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol (1997) 0.79
Treatment of anaemia in the polytrauma Jehovah's Witness. Ir Med J (2003) 0.79
Use of desmopressin and erythropoietin in an anaemic Jehovah's Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement. Perfusion (2001) 0.78
Preoperative administration of epoetin alfa to total joint arthroplasty patients. Orthopedics (2002) 0.78
Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study. Acta Haematol (1998) 0.78
Blood transfusion requirements in elderly hip fracture patients. Arch Gerontol Geriatr (2003) 0.78
Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery. Gynecol Obstet Invest (2002) 0.77
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. J Vasc Surg (2003) 0.77
Where does preoperative erythropoietin therapy count? A mathematical perspective. Transfusion (1999) 0.76
Autologous blood transfusion in radical hysterectomy with and without erythropoietin therapy. Obstet Gynecol (2002) 0.76
Anemia in patients with coronary artery disease. Am J Health Syst Pharm (2003) 0.76